It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: TheRedneck
a reply to: Serdgiam
I haven't found anything that shows ECGC as a zinc ionophore.
...
originally posted by: whereislogic
a reply to: Southern Guardian
... Typical. Reminds me of the way you use links to a news article about the retracted Lancet 'study' that still tries to use that publication as an argument against the use of HCQ in Covid-19, a.k.a. SARS-CoV-2 (official designation*). ...
So you are expert enough to decide who is and is not an expert?
originally posted by: Southern Guardian
a reply to: TheRedneck
So you are expert enough to decide who is and is not an expert?
You don't need to be an expert to recognize somebody like Birx, with years of medical experience and knowledge, appointed to the National Coronavirus Task Force, by POTUS himself, will have more of a valid intepretation of data and trends in comparison to a bunch of quack doctors?
Or are you talking about yourself?
Come back to me with those experts.
You don't need to be an expert to recognize somebody like Birx
Southern do you think it's more likely that Dr.Birx is the most expertly qualified doctor for the job
No, I suppose not. Apparently you can just be some clueless guy on the Internet.
I'm clueless for referring to more than qualified people on this matters
Nope. You're just clueless
Still throwing that line of BS, eh? Must be terrible not having enough imagination
It’s the best thing I’ve read on hydroxychloroquine. But beware: The piece is long and fascinating. Once you start reading, you won’t be able to stop, and it takes a good half hour to finish.
makes a discussion of research methodology interesting. Here is a sample:
We now have studies that show one of the weaknesses of RCTs (random controlled testing) is that in the quest to eliminate confounding factors, they end up, in a majority of cases, excluding patients who are typical of those in the population. The RCT evangelist focuses only on the RCT strengths, and forgets their weaknesses. A typical RCT describes several data points about hundreds of patients. It can be helpful in determining what treatment might work for most people in a large population. A typical case history describes perhaps hundreds of data points about a single patient. Its focus might be on what treatment might work best for this patient. Sometimes we need all that information about a patient, to choose a proper treatment, because individual patients differ, often in decisive ways.e
So while browsing the internet came across a little article on HCQ
if you’re here for a definitive answer to a narrow question about one specific drug (“does hydroxychloroquine work?”), you will be disappointed. Because what our tale is really concerned with is the perilous state of vulnerability of our scientific discourse, models, and institutions—which is arguably a much bigger, and more urgent problem,
So here then is a lesson: When scientific competitors, politicians, and the media, dump on a study for not showing X, make sure you know whether that study was even designed with the primary purpose of showing X to begin with.
Investigative journalist Sharyl Attkisson looked into the financial links of the members of that group that was suddenly restricting HCQ and giving the edge to remdesivir. When she and her team examined the ties of those on the committee, she found that a large number had ties with Gilead, the company that makes remdesivir, which costs $3,500 for several days' worth, and was emerging as the chief rival to HCQ. It was not just a few members either: “We found that of 11 members reporting links to a drug company, nine of them named relationships to remdesivir’s maker Gilead. Seven more, including two of the committee’s leaders, have ties to Gilead beyond the 11 months they had to disclose. Two were on Gilead’s advisory board. Others were paid consultants or received research support and honoraria.
it's lovely you think Zinc is the missing piece, where's the substance??
That would be the two studies from the NIH